Saudi - Delayed Quote SAR

Mouwasat Medical Services Company (4002.SR)

77.60
-0.60
(-0.77%)
At close: May 14 at 3:19:56 PM GMT+3
Currency in SAR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,879,372.34
2,879,372.34
2,705,508.12
2,334,112.28
2,144,143.11
Cost of Revenue
1,590,407.81
1,590,407.81
1,392,428.88
1,232,540.55
1,148,364.96
Gross Profit
1,288,964.54
1,288,964.54
1,313,079.24
1,101,571.74
995,778.15
Operating Expense
505,187.20
505,187.20
447,642.44
417,576.61
373,849.26
Operating Income
783,777.34
783,777.34
865,436.80
683,995.13
621,928.90
Net Non Operating Interest Income Expense
-18,475.35
-18,475.35
-39,974.37
-22,305.02
-7,877.20
Pretax Income
705,795.87
705,795.87
727,087.81
660,271.31
632,196.12
Tax Provision
36,185.71
36,185.71
38,699.07
27,583.65
21,734.76
Net Income Common Stockholders
645,759.04
645,759.04
657,687.91
599,305.26
578,161.35
Diluted NI Available to Com Stockholders
645,759.04
645,759.04
657,687.91
599,305.26
578,161.35
Basic EPS
3.23
--
3.29
3.00
2.89
Diluted EPS
3.23
--
3.29
3.00
2.89
Basic Average Shares
200,000
--
200,000
200,000
200,000
Diluted Average Shares
200,000
--
200,000
200,000
200,000
Total Operating Income as Reported
724,271.22
724,271.22
756,856.35
672,696.12
621,928.90
Rent Expense Supplemental
--
--
--
--
0
Total Expenses
2,095,595
2,095,595
1,840,071.33
1,650,117.16
1,522,214.22
Net Income from Continuing & Discontinued Operation
645,759.04
645,759.04
657,687.91
599,305.26
578,161.35
Normalized Income
719,022.94
719,022.94
768,425.83
616,584.41
578,176.33
Interest Income
11,979.96
11,979.96
6,482.14
575.34
321.85
Interest Expense
30,455.30
30,455.30
46,456.51
22,880.35
8,199.05
Net Interest Income
-18,475.35
-18,475.35
-39,974.37
-22,305.02
-7,877.20
EBIT
736,251.18
736,251.18
773,544.31
683,151.66
640,395.17
EBITDA
974,245.06
974,245.06
997,017.10
871,696.77
797,890.05
Reconciled Cost of Revenue
1,590,407.81
1,590,407.81
1,392,428.88
1,232,540.55
1,148,364.96
Reconciled Depreciation
237,993.89
237,993.89
223,472.78
188,545.11
157,494.88
Net Income from Continuing Operation Net Minority Interest
645,759.04
645,759.04
657,687.91
599,305.26
578,161.35
Total Unusual Items Excluding Goodwill
-77,223.08
-77,223.08
-116,963.27
-18,032.48
-15.52
Total Unusual Items
-77,223.08
-77,223.08
-116,963.27
-18,032.48
-15.52
Normalized EBITDA
1,051,468.14
1,051,468.14
1,113,980.36
889,729.24
797,905.57
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,959.18
-3,959.18
-6,225.34
-753.33
-0.53
12/31/2021 - 2/22/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4007.SR Al Hammadi Holding Company
39.90
-0.25%
 
4005.SR National Medical Care Company
162.40
-0.85%
 
4004.SR Dallah Healthcare Company
118.60
-1.66%
 
4017.SR Dr. Soliman Abdel Kader Fakeeh
46.35
-0.75%
 
4009.SR Middle East Healthcare Company
64.00
-1.54%
 
4013.SR Dr. Sulaiman Al Habib Medical Services Group Company
270.00
-0.22%
 
4018.SR Almoosa Health Company
164.00
-0.97%
 
9518.SR Canadian General Medical Center Complex Company
7.00
+1.16%
 
DVA DaVita Inc.
139.90
-2.83%